Status:
COMPLETED
Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients
Lead Sponsor:
Laboratoires Thea
Conditions:
Glaucoma
Eligibility:
All Genders
18-90 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the efficacy and safety of T2345 versus active comparator.
Eligibility Criteria
Inclusion
- Adult patients diagnosed with glaucoma
Exclusion
- Under 18.
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
404 Patients enrolled
Trial Details
Trial ID
NCT01156012
Start Date
September 1 2009
End Date
December 1 2010
Last Update
January 22 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Director
Clermont-Ferrand, France, 63000